The diverse attributes characterizing IGF2BP3, such as its widespread overexpression in various cancer types, its regulatory control over genes influencing cell growth, and its restricted presence in specific human organs, collectively position it as a prime candidate for cancer therapy. The gene discussed is IGF2BP3; the disease is cancer.